Search results
Results from the WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6]
Kleiner and Perkins provided $100,000 on the May closing, and acquired 20,000 shares of preferred stock from Genentech. [6] Swanson was made the president and treasurer of Genentech, and received a $2,500 per month salary, along with 25,000 shares. [6] This marked the end of Swanson's unemployment, and the beginning of his career at Genentech ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Genentech's board approved and recommended the deal, which offers $95 per share for the 44 percent of Genentech that Roche. Genentech (DNA) -- Swiss pharmaceutical giant Roche said Thursday it has ...
1966: A subsidiary company named Boehringer Ingelheim Hellas was founded and the company started business in Greece. A new factory was built close to Athens at Koropi; 1971: The foreign subsidiary, Boehringer Ingelheim Pharmaceuticals, Inc is founded in Ridgefield, Connecticut (USA). This site is soon expanded, and becomes the company's North ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Three former Genentech employees have been indicted for funneling trade secrets to biosimilar rival JHL Biotech. In a civil suit, Genentech is suing the employees, JHL, and its founders, who are ...
Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.